In our Center, the cell viability, the integrity of the bag, and the clonogenic assay were evaluated before the reinfusion of hematopoietic progenitor cells-apheresis (HPC-A). This quality control (QC) should be made 14 days before the reinfusion to the patient to have the result of the functional test on the proliferative capacity of hematopoietic progenitors.
Scerpa, M.c., Rossi, C., Daniele, N., Lanti, A., Adorno, G., Picardi, A., et al. (2014). A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant. TRANSFUSION, 54(3), 522-531 [10.1111/trf.12307].
A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant
Daniele, Nicola;Adorno, Gaspare;Picardi, Alessandra;Arcese, William;Amadori, Sergio;Isacchi, Giancarlo;Zinno, Francesco
2014-03-01
Abstract
In our Center, the cell viability, the integrity of the bag, and the clonogenic assay were evaluated before the reinfusion of hematopoietic progenitor cells-apheresis (HPC-A). This quality control (QC) should be made 14 days before the reinfusion to the patient to have the result of the functional test on the proliferative capacity of hematopoietic progenitors.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
